| scholarly article | Q13442814 |
| P356 | DOI | 10.1371/JOURNAL.PONE.0172925 |
| P8608 | Fatcat ID | release_exirddcvized7idnwwaj2u73mm |
| P932 | PMC publication ID | 5325569 |
| P698 | PubMed publication ID | 28234995 |
| P50 | author | Qing-Xiang Amy Sang | Q89359702 |
| P2093 | author name string | Martin A Schwartz | |
| Diego A R Zorio | |||
| Dale B Bosco | |||
| Ty J Lively | |||
| Mark D Roycik | |||
| Yonghao Jin | |||
| P2860 | cites work | Heart Disease and Stroke Statistics--2015 Update: A Report From the American Heart Association | Q22241921 |
| Control of stem cell fate by physical interactions with the extracellular matrix | Q24648041 | ||
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| The intermediate S1' pocket of the endometase/matrilysin-2 active site revealed by enzyme inhibition kinetic studies, protein sequence analyses, and homology modeling | Q28207951 | ||
| Design and therapeutic application of matrix metalloproteinase inhibitors | Q28212260 | ||
| Peptide substrate specificities and protein cleavage sites of human endometase/matrilysin-2/matrix metalloproteinase-26 | Q28214784 | ||
| Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment | Q28255124 | ||
| Cell adhesion: the molecular basis of tissue architecture and morphogenesis | Q28276573 | ||
| TIPs are tension-responsive proteins involved in myogenic versus adipogenic differentiation | Q28588203 | ||
| Proteolytic and non-proteolytic activation of human neutrophil progelatinase B | Q28618751 | ||
| Diet, lifestyle, and the risk of type 2 diabetes mellitus in women | Q29614196 | ||
| Role of YAP/TAZ in mechanotransduction | Q29615411 | ||
| Dynamics of fat cell turnover in humans | Q29615688 | ||
| Adipocyte differentiation from the inside out | Q29615690 | ||
| Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry | Q29618605 | ||
| Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases | Q34095979 | ||
| An established preadipose cell line and its differentiation in culture II. Factors affecting the adipose conversion | Q34509691 | ||
| Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. | Q54656315 | ||
| Matrix metalloproteinase inhibition affects adipose tissue mass in obese mice | Q57184248 | ||
| Sublines of mouse 3T3 cells that accumulate lipid | Q57310450 | ||
| Comparative sequence specificities of human 72- and 92-kDa gelatinases (type IV collagenases) and PUMP (matrilysin) | Q70461729 | ||
| Activation of human progelatinase A by collagenase and matrilysin: activation of procollagenase by matrilysin | Q71525451 | ||
| New thiol and sulfodiimine metalloproteinase inhibitors and their effect on human microvascular endothelial cell growth | Q74104811 | ||
| Targeting matrix metalloproteinases in human prostate cancer | Q78027350 | ||
| A pericellular collagenase directs the 3-dimensional development of white adipose tissue | Q34522343 | ||
| Adipocyte differentiation of bone marrow-derived mesenchymal stem cells: cross talk with the osteoblastogenic program | Q34853025 | ||
| Metalloproteases and adipogenesis: a weighty subject | Q35748020 | ||
| Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core | Q37024770 | ||
| Mechanical strain inhibits adipogenesis in mesenchymal stem cells by stimulating a durable beta-catenin signal | Q37034948 | ||
| The increasingly complex regulation of adipocyte differentiation. | Q37107513 | ||
| Obesity as a major risk factor for cancer. | Q37171959 | ||
| Adipogenic differentiation of human adult stem cells from bone marrow stroma (MSCs). | Q38344683 | ||
| Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation | Q38358677 | ||
| The PPARgamma antagonist T0070907 suppresses breast cancer cell proliferation and motility via both PPARgamma-dependent and -independent mechanisms. | Q39557593 | ||
| Individual and aggregate years-of-life-lost associated with overweight and obesity | Q39955483 | ||
| Obesity-induced inflammatory changes in adipose tissue. | Q40348859 | ||
| Inhibition of enzyme activity of and cell-mediated substrate cleavage by membrane type 1 matrix metalloproteinase by newly developed mercaptosulphide inhibitors | Q40396352 | ||
| Mechanical stretch inhibits myoblast-to-adipocyte differentiation through Wnt signaling. | Q40456541 | ||
| Control of adipocyte differentiation | Q40462294 | ||
| Temporal gene expression changes during adipogenesis in human mesenchymal stem cells | Q40662778 | ||
| T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities | Q40747044 | ||
| Regulation of gene expression and cell function by extracellular matrix. | Q40822181 | ||
| Release of biological activities from quiescent fibronectin by a conformational change and limited proteolysis by matrix metalloproteinases | Q41296037 | ||
| Detection of functional matrix metalloproteinases by zymography. | Q41948215 | ||
| Catalytic- and ecto-domains of membrane type 1-matrix metalloproteinase have similar inhibition profiles but distinct endopeptidase activities | Q42098702 | ||
| Peroxisome proliferator-activated receptor gamma antagonists decrease Na+ transport via the epithelial Na+ channel. | Q42459811 | ||
| Pharmacologic, pharmacokinetic, and therapeutic differences among ACE inhibitors | Q42541827 | ||
| Involvement of matrix metalloproteinases in the adipose conversion of 3T3-L1 preadipocytes. | Q42814385 | ||
| Fibronectin modulation of cell shape and lipogenic gene expression in 3T3-adipocytes | Q42820082 | ||
| Genetic and pharmacological inhibition of Rho-associated kinase II enhances adipogenesis. | Q42825868 | ||
| Human mesenchymal stem cells as an in vitro model for human adipogenesis | Q44279270 | ||
| Matrix metalloproteinase-2 and -9 levels in obese patients. | Q45901657 | ||
| Abdominal obesity and risk of ischemic stroke: the Northern Manhattan Stroke Study | Q48295292 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | adipogenesis | Q2824461 |
| P304 | page(s) | e0172925 | |
| P577 | publication date | 2017-02-24 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | A new synthetic matrix metalloproteinase inhibitor reduces human mesenchymal stem cell adipogenesis | |
| P478 | volume | 12 |
Search more.